[PDF][PDF] Lipid metabolism in cancer: New perspectives and emerging mechanisms
LA Broadfield, AA Pane, A Talebi, JV Swinnen… - Developmental Cell, 2021 - cell.com
Tumors undergo metabolic transformations to sustain uncontrolled proliferation, avoid cell
death, and seed in secondary organs. An increased focus on cancer lipid metabolism has …
death, and seed in secondary organs. An increased focus on cancer lipid metabolism has …
Acetyl-CoA metabolism in cancer
DA Guertin, KE Wellen - Nature Reviews Cancer, 2023 - nature.com
Few metabolites can claim a more central and versatile role in cell metabolism than acetyl
coenzyme A (acetyl-CoA). Acetyl-CoA is produced during nutrient catabolism to fuel the …
coenzyme A (acetyl-CoA). Acetyl-CoA is produced during nutrient catabolism to fuel the …
Statins: a repurposed drug to fight cancer
W Jiang, JW Hu, XR He, WL Jin, XY He - Journal of Experimental & …, 2021 - Springer
As competitive HMG-CoA reductase (HMGCR) inhibitors, statins not only reduce cholesterol
and improve cardiovascular risk, but also exhibit pleiotropic effects that are independent of …
and improve cardiovascular risk, but also exhibit pleiotropic effects that are independent of …
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
R Cunningham, CG Hansen - Clinical Science, 2022 - portlandpress.com
Tumorigenesis is a highly complex process, involving many interrelated and cross-acting
signalling pathways. One such pathway that has garnered much attention in the field of …
signalling pathways. One such pathway that has garnered much attention in the field of …
Emerging mechanisms and targeted therapy of ferroptosis in cancer
H Wang, Y Cheng, C Mao, S Liu, D Xiao, J Huang… - Molecular Therapy, 2021 - cell.com
Ferroptosis is an iron-and lipid reactive oxygen species (ROS)-dependent form of
programmed cell death that is distinct from other forms of regulatory cell death at the …
programmed cell death that is distinct from other forms of regulatory cell death at the …
Lipid metabolism in T cell signaling and function
T cells orchestrate adaptive immunity against pathogens and other immune challenges, but
their dysfunction can also mediate the pathogenesis of cancer and autoimmunity. Metabolic …
their dysfunction can also mediate the pathogenesis of cancer and autoimmunity. Metabolic …
[HTML][HTML] The potential use of simvastatin for cancer treatment: A review
JA Duarte, ALB de Barros, EA Leite - Biomedicine & Pharmacotherapy, 2021 - Elsevier
Statins, typically used to reduce lipid levels, have been rediscovered for exhibiting
anticancer activities. Among them, especially simvastatin may influence the proliferation …
anticancer activities. Among them, especially simvastatin may influence the proliferation …
Beyond lipid-lowering: effects of statins on cardiovascular and cerebrovascular diseases and cancer
Y Morofuji, S Nakagawa, K Ujifuku, T Fujimoto… - Pharmaceuticals, 2022 - mdpi.com
The 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, also known
as statins, are administered as first-line therapy for hypercholesterolemia, both as primary …
as statins, are administered as first-line therapy for hypercholesterolemia, both as primary …
Lipid metabolism reprogramming in renal cell carcinoma
Metabolic reprogramming is recognized as a hallmark of cancer. Lipids are the essential
biomolecules required for membrane biosynthesis, energy storage, and cell signaling …
biomolecules required for membrane biosynthesis, energy storage, and cell signaling …
Targeting mutant p53 for cancer treatment: moving closer to clinical use?
MJ Duffy, M Tang, S Rajaram, S O'Grady, J Crown - Cancers, 2022 - mdpi.com
Simple Summary Cancer is largely caused by genetic alterations such as mutations in a
group of genes known as cancer driver genes. Many of the key advances in cancer …
group of genes known as cancer driver genes. Many of the key advances in cancer …